Name | Number of supported studies | Average coverage | |
---|---|---|---|
classical monocyte | 26 studies | 38% ± 12% | |
non-classical monocyte | 22 studies | 40% ± 11% | |
monocyte | 13 studies | 31% ± 11% | |
macrophage | 6 studies | 28% ± 4% | |
dendritic cell | 3 studies | 26% ± 9% | |
intermediate monocyte | 3 studies | 58% ± 14% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 3 studies | 20% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 2746.92 | 577 / 578 | 78% | 3.51 | 899 / 1155 |
kidney | 36% | 128.63 | 32 / 89 | 66% | 2.76 | 595 / 901 |
breast | 44% | 120.27 | 204 / 459 | 56% | 2.04 | 626 / 1118 |
spleen | 100% | 1846.54 | 240 / 241 | 0% | 0 | 0 / 0 |
bladder | 38% | 305.33 | 8 / 21 | 50% | 2.56 | 251 / 504 |
pancreas | 13% | 33.50 | 41 / 328 | 70% | 2.95 | 125 / 178 |
uterus | 31% | 81.90 | 52 / 170 | 51% | 1.97 | 235 / 459 |
peripheral blood | 81% | 6660.10 | 755 / 929 | 0% | 0 | 0 / 0 |
stomach | 29% | 128.52 | 103 / 359 | 52% | 2.07 | 149 / 286 |
adipose | 78% | 528.61 | 944 / 1204 | 0% | 0 | 0 / 0 |
intestine | 32% | 129.36 | 310 / 966 | 46% | 1.89 | 242 / 527 |
lymph node | 0% | 0 | 0 / 0 | 72% | 11.73 | 21 / 29 |
esophagus | 22% | 70.92 | 325 / 1445 | 48% | 1.90 | 88 / 183 |
thymus | 30% | 65.93 | 194 / 653 | 36% | 0.89 | 220 / 605 |
skin | 9% | 18.00 | 158 / 1809 | 55% | 1.87 | 259 / 472 |
adrenal gland | 39% | 100.68 | 101 / 258 | 20% | 0.71 | 47 / 230 |
ovary | 17% | 44.88 | 30 / 180 | 42% | 1.09 | 181 / 430 |
liver | 32% | 108.58 | 72 / 226 | 20% | 0.46 | 83 / 406 |
tonsil | 0% | 0 | 0 / 0 | 51% | 1.84 | 23 / 45 |
blood vessel | 50% | 211.67 | 668 / 1335 | 0% | 0 | 0 / 0 |
prostate | 31% | 93.04 | 76 / 245 | 16% | 0.35 | 78 / 502 |
heart | 42% | 154.81 | 364 / 861 | 0% | 0 | 0 / 0 |
brain | 16% | 43.95 | 432 / 2642 | 15% | 0.58 | 103 / 705 |
muscle | 4% | 5.42 | 31 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.01 | 1 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0002376 | Biological process | immune system process |
GO_0005886 | Cellular component | plasma membrane |
GO_0004888 | Molecular function | transmembrane signaling receptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | CD300E |
Protein name | CD300e molecule CMRF35-like molecule 2 (CLM-2) (CD300 antigen-like family member E) (CMRF35-A5) (Immune receptor expressed on myeloid cells 2) (IREM-2) (Polymeric immunoglobulin receptor 2) (PIgR-2) (PIgR2) (Poly-Ig receptor 2) (CD antigen CD300e) |
Synonyms | CLM2 CMRF35A5 CD300LE IREM2 |
Description | FUNCTION: Probably acts as an activating receptor. . |
Accessions | ENST00000392619.2 ENST00000412268.1 C9JDD2 Q496F6 |